Nuveen Asset Management, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 204 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.8%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$17,739,000
-3.3%
213,362
-3.3%
0.01%0.0%
Q2 2022$18,348,000
-20.3%
220,695
+12.3%
0.01%0.0%
Q1 2022$23,016,000
+9.6%
196,518
-1.5%
0.01%
+16.7%
Q4 2021$21,001,000
-29.6%
199,459
-9.8%
0.01%
-33.3%
Q3 2021$29,843,000
+33.9%
221,056
-3.7%
0.01%
+28.6%
Q2 2021$22,281,000
+45.5%
229,516
+2.4%
0.01%
+40.0%
Q1 2021$15,318,000
-51.9%
224,109
-39.7%
0.01%
-54.5%
Q4 2020$31,835,000
+77.7%
371,433
+34.8%
0.01%
+57.1%
Q3 2020$17,919,000
-18.6%
275,634
-8.5%
0.01%
-22.2%
Q2 2020$22,016,000
+251.1%
301,130
+63.4%
0.01%
+200.0%
Q1 2020$6,270,000
-75.2%
184,254
-60.4%
0.00%
-70.0%
Q4 2019$25,304,000
-30.0%
464,807
-46.4%
0.01%
-33.3%
Q3 2019$36,174,000
-6.8%
867,072
-2.1%
0.02%0.0%
Q2 2019$38,799,000886,0250.02%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 896,844$123,594,00067.92%
RP Management, LLC 1,111,111$153,122,00064.09%
ORACLE INVESTMENT MANAGEMENT INC 2,075,402$286,011,00040.64%
ARS Investment Partners, LLC 463,392$63,860,0005.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 300,373$41,394,0004.76%
SILVERARC CAPITAL MANAGEMENT, LLC 80,348$11,073,0004.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,900$19,282,0004.30%
Avidity Partners Management LP 1,140,000$157,103,0003.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$27,562,0003.17%
Eventide Asset Management 1,635,000$225,319,0002.88%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders